195 related articles for article (PubMed ID: 8895343)
21. Multiple domains interacting with Gs in the porcine calcitonin receptor.
Orcel P; Tajima H; Murayama Y; Fujita T; Krane SM; Ogata E; Goldring SR; Nishimoto I
Mol Endocrinol; 2000 Jan; 14(1):170-82. PubMed ID: 10628756
[TBL] [Abstract][Full Text] [Related]
22. Insights into interactions between the alpha-helical region of the salmon calcitonin antagonists and the human calcitonin receptor using photoaffinity labeling.
Pham V; Dong M; Wade JD; Miller LJ; Morton CJ; Ng HL; Parker MW; Sexton PM
J Biol Chem; 2005 Aug; 280(31):28610-22. PubMed ID: 15929987
[TBL] [Abstract][Full Text] [Related]
23. Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript.
Moore EE; Kuestner RE; Stroop SD; Grant FJ; Matthewes SL; Brady CL; Sexton PM; Findlay DM
Mol Endocrinol; 1995 Aug; 9(8):959-68. PubMed ID: 7476993
[TBL] [Abstract][Full Text] [Related]
24. Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product.
Zumpe ET; Tilakaratne N; Fraser NJ; Christopoulos G; Foord SM; Sexton PM
Biochem Biophys Res Commun; 2000 Jan; 267(1):368-72. PubMed ID: 10623626
[TBL] [Abstract][Full Text] [Related]
25. Structure/function relationships of calcitonin analogues as agonists, antagonists, or inverse agonists in a constitutively activated receptor cell system.
Pozvek G; Hilton JM; Quiza M; Houssami S; Sexton PM
Mol Pharmacol; 1997 Apr; 51(4):658-65. PubMed ID: 9106632
[TBL] [Abstract][Full Text] [Related]
26. Glycosylation is important for binding to human calcitonin receptors.
Ho HH; Gilbert MT; Nussenzveig DR; Gershengorn MC
Biochemistry; 1999 Feb; 38(6):1866-72. PubMed ID: 10026267
[TBL] [Abstract][Full Text] [Related]
27. Homologous regulation of the rat C1a calcitonin receptor (CTR) in nonosteoclastic cells is independent of CTR messenger ribonucleic acid changes and cyclic adenosine 3',5'-monophosphate-dependent protein kinase activation.
Findlay DM; Houssami S; Christopoulos G; Sexton PM
Endocrinology; 1996 Nov; 137(11):4576-85. PubMed ID: 8895320
[TBL] [Abstract][Full Text] [Related]
28. des-Ser2 salmon calcitonin: a biologically potent synthetic analog.
Schwartz KE; Orlowski RC; Marcus R
Endocrinology; 1981 Mar; 108(3):831-5. PubMed ID: 6257497
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase-C-induced down-regulation of calcitonin receptors and calcitonin-activated adenylate cyclase in T47D and BEN cells.
Findlay DM; Michelangeli VP; Robinson PJ
Endocrinology; 1989 Nov; 125(5):2656-63. PubMed ID: 2551660
[TBL] [Abstract][Full Text] [Related]
30. Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts.
Wada S; Udagawa N; Nagata N; Martin TJ; Findlay DM
Endocrinology; 1996 Mar; 137(3):1042-8. PubMed ID: 8603572
[TBL] [Abstract][Full Text] [Related]
31. A human orphan calcitonin receptor-like structure.
Flühmann B; Muff R; Hunziker W; Fischer JA; Born W
Biochem Biophys Res Commun; 1995 Jan; 206(1):341-7. PubMed ID: 7818539
[TBL] [Abstract][Full Text] [Related]
32. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
Van Rampelbergh J; Gourlet P; De Neef P; Robberecht P; Waelbroeck M
Mol Pharmacol; 1996 Dec; 50(6):1596-604. PubMed ID: 8967982
[TBL] [Abstract][Full Text] [Related]
33. Adenylate cyclase activation and competitive binding with renal tissue using synthetic eel calcitonin analog and its fragments.
Yamamoto I; Morita R; Fukunaga M; Dokoh S; Shigeno C; Torizuka K; Noda T
Endocrinology; 1981 Feb; 108(2):698-702. PubMed ID: 7449744
[TBL] [Abstract][Full Text] [Related]
34. A noncyclical analog of salmon calcitonin (N alpha-propionyl Di-Ala1,7,des-Leu19 sCT) retains full potency without inducing anorexia in rats.
Yates AJ; Gutierrez GE; Garrett IR; Mencel JJ; Nuss GW; Schreiber AB; Mundy GR
Endocrinology; 1990 Jun; 126(6):2845-9. PubMed ID: 2351097
[TBL] [Abstract][Full Text] [Related]
35. The biological potency of a series of analogues of human calcitonin correlates with their interactions with phospholipids.
Epand RF; Orlowski RC; Epand RM
Biopolymers; 2004; 76(3):258-65. PubMed ID: 15148685
[TBL] [Abstract][Full Text] [Related]
36. Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity.
Runge S; Wulff BS; Madsen K; Bräuner-Osborne H; Knudsen LB
Br J Pharmacol; 2003 Mar; 138(5):787-94. PubMed ID: 12642379
[TBL] [Abstract][Full Text] [Related]
37. Roles of specific extracellular domains of the glucagon receptor in ligand binding and signaling.
Unson CG; Wu CR; Jiang Y; Yoo B; Cheung C; Sakmar TP; Merrifield RB
Biochemistry; 2002 Oct; 41(39):11795-803. PubMed ID: 12269822
[TBL] [Abstract][Full Text] [Related]
38. Structural determinants of salmon calcitonin bioactivity: the role of the Leu-based amphipathic alpha-helix.
Andreotti G; Méndez BL; Amodeo P; Morelli MA; Nakamuta H; Motta A
J Biol Chem; 2006 Aug; 281(34):24193-203. PubMed ID: 16766525
[TBL] [Abstract][Full Text] [Related]
39. Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor.
Samura A; Wada S; Suda S; Iitaka M; Katayama S
Endocrinology; 2000 Oct; 141(10):3774-82. PubMed ID: 11014233
[TBL] [Abstract][Full Text] [Related]
40. N-Glycosylation of Asparagine 130 in the Extracellular Domain of the Human Calcitonin Receptor Significantly Increases Peptide Hormone Affinity.
Lee SM; Booe JM; Gingell JJ; Sjoelund V; Hay DL; Pioszak AA
Biochemistry; 2017 Jul; 56(26):3380-3393. PubMed ID: 28614667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
